Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Stem Cells Could Set Up Future Transplant Therapies

Published: Thursday, October 31, 2013
Last Updated: Thursday, October 31, 2013
Bookmark and Share
New method for developing stem cells enables production of liver and pancreatic cells in clinically relevant quantities.

Scientists have developed a new method for creating stem cells for the human liver and pancreas. This method could enable both cell types to be grown in sufficient quantities for clinical use.

Using the technique, researchers have for the first time been able to grow a pure, self-renewing population of stem cells specific to the human foregut - the section of the digestive system that includes the liver and pancreas. These digestive cells could then be developed further to produce liver or pancreatic cells.

Stem cells have the potential to be used to replace dying or damaged cells with healthy cells and have potential wide-ranging uses in medicine such as organ replacement, bone replacement and treatment of neurodegenerative diseases.

This method significantly improves on existing techniques for cultivating these stem cells and raises the possibility that, with further work, they could be grown in large numbers. That would make it possible to use them for regenerative therapies, such as repairing damaged organs or tissues in the body.

"We have developed a cell culture system which allows us to specifically isolate foregut cells in the lab," Dr Nicholas Hannan, from the University of Cambridge Wellcome Trust MRC Stem Cell Institute, Department for Surgery, explained. Hannan led the study, which was carried out in the lab of Dr Ludovic Vallier, joint Faculty member of the Wellcome Trust Sanger Institute and the University of Cambridge.

"These cells have huge implications for regenerative medicine, because they are the precursors to the thyroid, upper airways, lungs, liver, pancreas, stomach and biliary systems. We now have a system where we may be able to create all these cell types from the same starting population."

To grow pancreatic or liver cells, stem cells are differentiated into the endoderm - the primary tissue layer associated with the digestive and respiratory systems. This provides a base population of cells that researchers can then try to develop as more specialised cells, such as heart or lung cells. Unfortunately, other cell types can grow, making it difficult to identify the target cells in the lab and complicating the application of these cells in transplant therapies.

The new approach overcomes some of these problems that currently limit scientists’ ability to grow cells associated with this region in sufficiently large numbers for clinical use.

By manipulating the signal pathways of the cells and varying the environment in which the cells were developed, researchers were able to isolate the precise treatments needed to drive differentiation of cells associated with the foregut itself. When heavily contaminated stem cell populations were developed under these conditions, the contaminating cells eventually died out.

The universal nature of this culture system takes a step towards a universal system that could be used to treat any patient requiring cells for transplantation purposes.

The cells generated are true stem cells because they are able to self-renew and can differentiate towards any part of the foregut. Because they are also still at the stage where they can self-renew, they can be grown in large enough numbers to be used in clinical therapies. The team was also able to show that these human foregut stem cells do not form tumours, which means that they could be safely injected for therapeutic purposes, without having adverse side effects.

"What we have now is a better starting point - a sustainable platform for producing liver and pancreatic cells," Dr Ludovic Vallier, senior author of the study, said. "It will improve the quality of the cells that we produce and it will allow us to produce the large number of uncontaminated cells we need for the clinical application of stem cell therapy."


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Seeking Superior Stem Cells
One hundred-fold increase in efficiency in reprogramming human cells to induced stem cells.
Friday, December 30, 2011
Scientific News
The Mending Tissue - Cellular Instructions for Tissue Repair
NUS-led collaborative study identifies universal mechanism that explains how tissue shape regulates physiological processes such as wound healing and embryo development.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
iPS Cells Discover Drug Target for Muscle Disease
Researchers have designed a model that reprograms fibroblasts to the early stages of their differentiation into intact muscle cells in a step towards a therapeutic for Duchenne muscular dystrophy.
Engineered Hot Fat Implants Reduce Weight Gain
Scientists at UC Berkeley have developed a novel way to engineer the growth and expansion of energy-burning “good” fat, and then found that this fat helped reduce weight gain and lower blood glucose levels in mice.
Transplanted Stem Cells Can Benefit Retinal Disease Sufferers
Tests on animal models show that MSCs secrete growth factors that suppress causes of diabetic retinopathy and macular degeneration.
MRI Scanners Can Steer Therapeutics to Specific Target Sites
Scientists from the University of Sheffield have discovered MRI scanners, normally used to produce images, can steer cell-based, tumour busting therapies to specific target sites in the body.
Team Finds Early Inflammatory Response Paralyzes T Cells
Findings could have enormous implications for immunotherapy, autoimmune disorders, transplants and other aspects of immunity.
Early Detection of Lung Cancer
The University of Manchester has signed a collaboration agreement with Abcodia to perform proteomics studies on a cohort of non-small cell lung cancer cases from the UKCTOCS biobank, with the aim of discovering new blood-based biomarkers for earlier detection of the disease.
Researchers Identify Drug Candidate for Skin, Hair Regeneration
Formerly undiscovered role of protein may lead to the development of new medications that stimulate hair and skin regeneration in trauma or burn victims.
Basis for New Treatment Options for a Fatal Leukemia in Children Revealed
Detailed molecular analyses allow new insights into the function of tumour cells and options for new treatments.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!